Optimal Light Dose for hEGFR-Targeted Near-Infrared Photoimmunotherapy

SIMPLE SUMMARY: Near-infrared photoimmunotherapy (NIR-PIT) is a cancer therapy that selectively destroys target cells by first injecting monoclonal antibodies conjugated with a photon absorber (IRDye700DX) into the subject and then activating it at the tumor site by applying nonthermal doses of NIR...

Descripción completa

Detalles Bibliográficos
Autores principales: Furumoto, Hideyuki, Okada, Ryuhei, Kato, Takuya, Wakiyama, Hiroaki, Inagaki, Fuyuki, Fukushima, Hiroshi, Okuyama, Shuhei, Furusawa, Aki, Choyke, Peter L., Kobayashi, Hisataka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406827/
https://www.ncbi.nlm.nih.gov/pubmed/36011036
http://dx.doi.org/10.3390/cancers14164042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406827/
https://www.ncbi.nlm.nih.gov/pubmed/36011036
http://dx.doi.org/10.3390/cancers14164042

Ejemplares similares